Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment

Tremendous data have been accumulated in the effort to understand chemoresistance of triple negative breast cancer (TNBC). However, modifications in cancer cells surviving combined and sequential treatment still remain poorly described. In order to mimic clinical neoadjuvant treatment, we first trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Marie, Meignan, Samuel, Völkel, Pamela, Angrand, Pierre-Olivier, Chopin, Valérie, Bidan, Nadège, Toillon, Robert-Alain, Adriaenssens, Eric, Lagadec, Chann, Le Bourhis, Xuefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232646/
https://www.ncbi.nlm.nih.gov/pubmed/34203746
http://dx.doi.org/10.3390/cells10061504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232646/
https://www.ncbi.nlm.nih.gov/pubmed/34203746
http://dx.doi.org/10.3390/cells10061504

Ejemplares similares